Please enter the keywords
SCI papers published in 2021

SCI papers published in 2021

Sun Yuanjie, Liu Zhishun*.《Annals of Internal Medicine》. (IF:25.391). Efficacy of Acupuncture for Chronic Prostatitis/Chronic Pelvic Pain Syndrome : A Randomized Trial.

Zhang Xing, Hua Baojin *.《Gastroenterology》. (IF:22.682). Reply to"Does Endoscopic Screening Really Not Alter the Incidence of Gastric Cancer?".
Su Xin, Xing Yanwei*.《Seminars in Cancer Biology》. (IF:15.707). Advances in the application of nanotechnology in reducing cardiotoxicity induced by cancer chemotherapy.
Han Man, Jiang Quan *.《Cellular & Molecular Immunology》. (IF:11.530). New insights into follicular helper T cell response and regulation in autoimmune pathogenesis.
Sun Yuanjie, Liu Zhishun*.《American Journal of Gastroenterology》. (IF:10.864). Response to Philips and Abraham.
Pang Ran,Pang Ran*.《Cochrane Database of Systematic Reviews》. (IF:9.266). Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction.
Su Liang, Jiao Yongzheng*.《Advances in Nutrition》. (IF:8.701). Effect of Antioxidants on Sperm Quality Parameters in Subfertile Men: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Liu Can,Xing Yanwei*.《Pharmacological Research》. (IF:7.658). Relevance of mitochondrial oxidative stress to arrhythmias: Innovative concepts to target treatments.
Han Man,Jiang Quan*.《Frontiers in Immunology》. (IF:7.561). The Multiple Roles of B Cells in the Pathogenesis of Sjögren's Syndrome.
Lyu Wenliang, Lyu Wenliang *.《Hepatobiliary Surgery and Nutrition》. (IF:7.293). Understanding traditional Chinese medicine.
Zhang Yuqing,Lian Fengmei/Tong Xiaolin*.《Frontiers in Cell and Developmental Biology》. (IF:6.684). Signaling Pathways Involved in Diabetic Renal Fibrosis.
Li Dan,Wu Min*.《Frontiers in Cell and Developmental Biology》. (IF:6.684). Novel Insights and Current Evidence for Mechanisms of Atherosclerosis: Mitochondrial Dynamics as a Potential Therapeutic Target.
Yang Fan,Xing Yanwei*.《Frontiers in Nutrition》. (IF:6.576). Effect of Epidemic Intermittent Fasting on Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Wang Xinmiao,Li Jie*.《Frontiers in Nutrition》. (IF:6.576). Efficacy and Safety of Brucea javanica Oil Emulsion Injection in the Treatment of Gastric Cancer: A Systematic Review and Meta-Analysis.
Su Xin,Xing Yanwei*.《Oxidative Medicine and Cellular Longevity》. (IF:6.543). The Beneficial Effects of Saffron Extract on Potential Oxidative Stress in Cardiovascular Diseases.
Xiang Mi/Lu Yingdong, Cui Xiangning*.《Oxidative Medicine and Cellular Longevity》. (IF:6.543). Role of Oxidative Stress in Reperfusion following Myocardial Ischemia and Its Treatments.
Li xinye,Xing Yanwei*.《Oxidative Medicine and Cellular Longevity》. (IF:6.543). Targeting Ferroptosis: Pathological Mechanism and Treatment of Ischemia-Reperfusion Injury.
Chang Xing, Liu Ruxiu *.《Oxidative Medicine and Cellular Longevity》. (IF:6.543). Tongyang Huoxue Decoction (TYHX) Ameliorating Hypoxia/Reoxygenation-Induced Disequilibrium of Calcium Homeostasis and Redox Imbalance via Regulating Mitochondrial Quality Control in Sinoatrial Node Cells.
Meng Peipei,He Qingyong*.《Oxidative Medicine and Cellular Longevity》. (IF:6.543). Molecular mechanism of astragaloside IV in improving endothelial dysfunction of cardiovascular dieseases mediated by oxidative stress.
He Qingyong.《Oxidative Medicine and Cellular Longevity》. (IF:6.543). Shexiang Baoxin Pill for Acute Myocardial Infarction: Clinical Evidence and Molecular Mechanism of Antioxidative Stress.
An Xuedong,Lian Fengmei/Tong Xiaolin*.《Biomedicine & Pharmacotherapy》. (IF:6.529). The Direct Evidence and Mechanism of Traditional Chinese Medicine Treatment of COVID-19.
Li Yaoyuan,Hua Baojin*.《Biomedicine & Pharmacotherapy》. (IF:6.529). Can Src protein tyrosine kinase inhibitors be combined with opioid analgesics? Src and opioid-induced tolerance, hyperalgesia and addiction.
Duan Liyun, Liu Xinmin/Lian Fengmei*.《Biomedicine & Pharmacotherapy》. (IF:6.529). Gut microbiota as the critical correlation of polycystic ovary syndrome and type 2 diabetes mellitus.
Li Yaoyuan,Hua Baojin*.《Biomedicine & Pharmacotherapy》. (IF:6.529). The nonreceptor protein tyrosine kinase Src participates in every step of cancer-induced bone pain.
Chen Xin,Zheng Honggang *.《Frontiers in Oncology》. (IF:6.244). Ultra-Performance Liquid Chromatography/Mass Spectrometry-Based Metabolomics for Discovering Potential Biomarkers and Metabolic Pathways of Colorectal Cancer in Mouse Model (ApcMin/+) and Revealing the Effect of Honokiol.
Cheng Mengqi,Hua Baojin*.《Frontiers in Oncology》. (IF:6.244). Efficacy and Safety of Astragalus-Containing Traditional Chinese Medicine Combined With Platinum-Based Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis.
Wu Min,Wu Min*.《Frontiers in Cardiovascular Medicine》. (IF:6.050). Mechanisms of Atherosclerosis Induced by Postprandial Lipemia.
Yuan Guozhen,Hu Yuanhui*.《Frontiers in Cardiovascular Medicine》. (IF:6.050). Cardiac Rehabilitation: A Bibliometric Review From 2001 to 2020.
Yang Xinyu,Xing Yanwei*.《Frontiers in Cardiovascular Medicine》. (IF:6.050). Potential Gene Association Studies of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis.
Zhou Yan,Hu Yuanhui*.《Frontiers in Cardiovascular Medicine》. (IF:6.050). The Role of the VEGF Family in Coronary Heart Disease.
Wu Min.《Frontiers in Cardiovascular Medicine》. (IF:6.050). Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview.
Zheng Qi, Zhang Ying /Hou Wei*.《Frontiers in Cardiovascular Medicine》. (IF:6.050). Use of Anti-angiogenic Drugs Potentially Associated With an Increase on Serum AST, LDH, CK, and CK-MB Activities in Patients With Cancer: A Retrospective Study.
Jin De,Lian Fengmei/Tong Xiaolin*.《Frontiers in Pharmacology》. (IF:5.810). Potential Mechanism Prediction of Herbral Medicine for Pulmonary Fibrosis Associated with SARS-CoV-2 Infection Based on Network Analysis and Molecular Docking.
Jin De,Lian Fengmei*.《Frontiers in Pharmacology》. (IF:5.810). Efficacy and Safety of TangWang Prescription for Type 2 Non-Proliferative Diabetic Retinopathy: A Study Protocol for a Randomized Controlled Trial.
Zhang Yuehong,Lian Fengmei/Tong Xiaolin*.《Frontiers in Pharmacology》. (IF:5.810). Efficacy of Mudan Granule (Combined With Methylcobalamin) on Type 2 Diabetic Peripheral Neuropathy: Study Protocol for a Double-Blind, Randomized, Placebo-Controlled, Parallel-Arm, Multi-Center Trial.
Zhu Guanghui,Li Jie*.《Frontiers in Pharmacology》. (IF:5.810). Evaluation of Efficacy and Safety for Kanglaite Injection in the Control of the Malignant Pleural Effusions via Thoracic Perfusion: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Zhang Yuehong,Lian Fengmei*.《Frontiers in Pharmacology》. (IF:5.810). Lychee Seed as a Potential Hypoglycemic Agent, and Exploration of its Underlying Mechanisms.
Jin De,Lian Fengmei/Tong Xiaolin*.《Frontiers in Pharmacology》. (IF:5.810). Panax Ginseng C.A.Mey. as Medicine: The Potential Use of Panax Ginseng C.A.Mey. as a Remedy for Kidney Protection from a Pharmacological Perspective.
Yang Shengjie,Wu Min*.《Frontiers in Pharmacology》. (IF:5.810). Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota.
Gong Xun,Jiang Quan*.《Frontiers in Pharmacology》. (IF:5.810). Traditional Chinese Medicine Qingre Huoxue Treatment vs. the Combination of Methotrexate and Hydroxychloroquine for Active Rheumatoid Arthritis: A Multicenter, Double-Blind, Randomized Controlled Trial.
Wang Heping,Li Jie*.《Frontiers in Pharmacology》. (IF:5.810). Efficacy and Safety of Traditional Chinese Medicine in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis.
Liu Tongtong,Zhan Yongli*.《Frontiers in Pharmacology》. (IF:5.810). Knowledge Domain and Emerging Trends in Podocyte Injury Research From 1994 to 2021: A Bibliometric and Visualized Analysis.
Zhou Rongrong,Lian Fengmei/Tong Xiaolin*.《Frontiers in Pharmacology》. (IF:5.810). Dosage Modification of Traditional Chinese Medicine Prescriptions: An Analysis of Two Randomized Controlled Trials.
Zhao Yiqian,Wu Min*.《Frontiers in Pharmacology》. (IF:5.810). Mechanism of Improving Aspirin Resistance: Blood-Activating Herbs Combined With Aspirin in Treating Atherosclerotic Cardiovascular Diseases.
Lian Fengmei*.《Aging (Albany NY)》. (IF:5.682). Decoding the chemical composition and pharmacological mechanisms of Jiedu Tongluo Tiaogan Formula using high-performance liquid chromatography coupled with network pharmacology-based investigation.
Dong Guangtong,Wei Junping/Hou Wei*.《Respiratory Research》. (IF:5.631). Effects of diabetes on the development of radiation pneumonitis.
Li Jun,Wei Junping*.《Frontiers in Endocrinology》. (IF:5.555). Effect of Addition of Thyroxine in the Treatment of Graves’ Disease: A Systematic Review.
Chen Yinying, Wang Jie*.《Journal of Translational Medicine》. (IF:5.531). Prediction of hepatocellular carcinoma risk in patients with chronic liver disease from dynamic modular networks.
Chen Hairong,Tong Xiaolin*.《Journal of Oral Microbiology》. (IF:5.474). Microbial characteristics across different tongue coating types in a healthy population.
Han Lin,Zhao Linhua/Tong Xiaolin*.《Chinese Medicine》. (IF:5.455). Potential mechanism prediction of Cold-Damp Plague Formula against COVID-19 via network pharmacology analysis and molecular docking.
An Xuedong,Lian Fengmei/Tong Xiaolin*.《Chinese Medicine》. (IF:5.455). The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19.
Han Lin,Zhao Linhua/Tong Xiaolin*.《Chinese Medicine》. (IF:5.455). Mechanism exploration of Gouqi-wentang formula against type 2 diabetes mellitus by phytochemistry and network pharmacology-based analysis and biological validation.
Shang Chang, Cui Xiangning *.《Food & Function》. (IF:5.396). Beneficial effects of cinnamon and its extracts in the management of cardiovascular diseases and diabetes.
Zheng Yujiao,Li Min/Tong Xiaolin*.《Phytomedicine》. (IF:5.340). Effect of traditional Chinese medicine on gut microbiota in adults with type 2 diabetes: a systematic review and meta-analysis.
Tian Jiaxing,Li Min/Tong Xiaolin*.《Frontiers in Cellular and Infection Microbiology》. (IF:5.293). Alleviation Effects of GQD, a Traditional Chinese Medicine Formula, on Diabetes Rats Linked to Modulation of the Gut Microbiome.
HanYi《Arthritis Research & Therapy》. (IF:5.156). Isopsoralen ameliorates rheumatoid arthritis by targeting MIF.
Zheng Yujiao,Lian Fengmei/Tong Xiaolin*.《Frontiers in Medicine》. (IF:5.091). Understanding COVID-19 in Wuhan from the perspective of cold-dampness: clinical evidences and mechanisms.
An Xuedong,Lian Fengmei/Tong Xiaolin*.《Frontiers in Medicine》. (IF:5.091). Efficacy of Jinhua Qinggan Granules Combined With Western Medicine in the Treatment of Confirmed and Suspected COVID-19: A Randomized Controlled Trial.

Previous Article
Next Article